Government Record Examines Heart Attack Risk inside Avandia:

 

The drug Avandia was okayed in the U.S. within 1998 for the treatment of being overweight by controlling blood sugar levels. Countless diabetics have taken the medicine, but in recent years, sales include declined due to reports about a increased risk of potentially life-threatening heart risks.  In May ’07, the New England Journal of medication published a report on the study of 42 clinical trials carried out by GlaxoSmithKline, the manufacturer of Avandia, which proposed that patients using Avandia has a 43% increase risk of heart attack.  This short article brought wide spread attention to potential risk of heart problems for users of Avandia.  A recent report by the Chair for economic council committee has determined that GlaxoSmithKline knew about the risk of which Avandia caused heart problems, but did not inform the FDA.  This kind of report also brought to light which some FDA drug wellbeing reviewers have been asking for a strong Avandia recall since 2007,  right after their two-year examination of these medical study results.